AKITA, by Finnadvance
The startup operates a biomimetic drug discovery platform that recreates micro-physiological conditions to enhance drug research efficiency. By providing reliable evaluations of drug efficacy and toxicology, the platform enables researchers to develop new therapies more cost-effectively, ultimately improving patient health outcomes.
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$2.4MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup operates a biomimetic drug discovery platform that recreates micro-physiological conditions to enhance drug research efficiency. By providing reliable evaluations of drug efficacy and toxicology, the platform enables researchers to develop new therapies more cost-effectively, ultimately improving patient health outcomes.